Non-compressible torso hemorrhage (NCTH) is a leading cause of potentially survivable death in United States (U.S.) warfighters and commonly occurs after traumatic injury. A study of 4,596 battlefield fatalities from Operation Iraqi Freedom and Operation Enduring Freedom determined that hemorrhage accounted for 91% of potentially survivable fatalities occurring prior to arrival at a Medical Treatment Facility.1 Additionally, of those 888 deaths attributable to hemorrhage, 67% were from NCTH. This supports the vital need for intervention in far forward military environments. 410 Medical, Inc, with subcontractor, Certus Critical Care, Inc., proposes to develop their Transfusion and Endovascular Resuscitation v 1.0 (TiER-1) platform, combining innovative devices into an integrated automated acute resuscitation platform to care for the wounded warfighter requiring early stabilization while awaiting definitive hemorrhage control for Non-compressible truncal hemorrhage (NCTH). There are currently no commercially available provider-in-the-loop resuscitation platforms marketed in the civilian sector which provide the level of care as the TiER-1 system.
